Ad26.COV2.S
COVID-19 vaccine of Johnson & Johnson
Facts
9 properties- Instance of
- funded product, chemical substance[2]
- Subclass of
- adenovirus-based vaccine, vaccine candidate, COVID-19 vaccine[9][10][11]
- Described by source
- Ad26-vector based COVID-19 vaccine encoding a prefusion stabilized SARS-CoV-2 Spike immunogen induces potent humoral and cellular immune responses, A Study of Ad26COVS1 in Adults, A Study of Ad26.COV2.S for the Prevention of SARS-CoV-2-Mediated COVID-19 in Adult Participants[13][14][15]
- Manufacturer
- Emergent BioSolutions, Catalent Pharma Solutions, Biological E. Limited, Grand River Aseptic Manufacturing[3][4][5][6]
- Price
- 8.5[17]
- Route of administration
- intramuscular injection[12]
🏷️ Also known as
en Jcovden
en Ad26.COV2.S
en Jhon
en Ad26COVS1
en Dutch vaccine
en J7
en Janssen vaccine
cs vakcína od Johnson & Johnson
el Εμβόλιο covid19 της Johnson & Johnson
es Vacuna de Janssen
es Vacuna Janssen
es Vacunas Janssen
fa واکسن کووید-۱۹ جانسون اند جانسون
fi Janssenin COVID-19-rokote
fr vaccin Janssen
hu Janssen-Covid19-vakcina
id Vaksin COVID-19 Johnson & Johnson
it vaccino J&J
it Ad26.COV2.S
it vaccino Janssen anti COVID-19
🔖 Identifiers · 9
- DrugBank ID
- DB15857
- Google Knowledge Graph ID
- /g/11ll0qhr92
- MeSH descriptor ID
- D000090984
- MeSH tree code
- D20.215.894.899.085.125
- MedlinePlus drug identifier
- a621007
- UNII
- JT2NS6183B
- VIOLIN ID
- 5782
- Vaccine Ontology ID
- VO_0005159
- WikiProjectMed ID
- Janssen COVID-19 vaccine
🔗 Connections
Instance of 1
Route of administration 1
Subclass of 1
Vaccine for 1
← Has use 1
Press Enter · cited answer in seconds
0 sources
Summary
Ad26.COV2.S is a funded product[1].